 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
Benedetto Vitiello, MD, Child Treatment Branch, National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD 20892, Julie M. Zito, PhD, Pharmacy Practice and Science, University of Maryland, 100 N. Greene St, Baltimore, MD 21201, 410 706 0524, bv5r@nih.gov, Clarke Ross, PhD, Executive Director, Children and Adults with Attention Deficit Disorder (CHADD), 8181 Professional Place, Suite 201, Landover, MD 20785, and Deborah Zarin, MD, Office of Technology Assessment, Agency for Health Care Research and Policy, 2101 E. Jefferson St., Suite 501, Rockville, MD 20852.
This session aims to update a broad public health audience on the scientific findings related to the diagnosis and treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Because of the rapid increase in the identification and medication treatment of ADHD, particularly in very young children, the topic is controversial. Disparate viewpoints in health care require detailed dialogue so that the public health community can find common ground and identify gaps in the scientific knowledge base or practice environment.
· A Government Viewpoint on ADHD Research and Practice
Dr. Ben Vitiello, NIMH Child Treatment Psychopathology Branch Chief Dr. Vitiello has written extensively on the efficacy and safety issues related to medication use among young children. His presentation will address the strengths and weaknesses of the current system for research, regulation and quality improvement of practice using ADHD as a model case. He will highlight areas of strong evidence for medication and behavioral interventions as well as areas where the evidence base needs further research and with what methods.
· Interpreting ADHD-related Prescription Patterns
Julie Zito, PhD, U of Maryland, will briefly review community-based utilization trends on the leading medications for the treatment of ADHD across a decade. She will propose 5 questions that are generated by the expanded usage.
· A Consumer Advocacy Viewpoint on ADHD Research and Practice
Clarke Ross, PhD, Executive Director of Children and Adults with Attention Deficit Disorder (CHADD), a national advocacy group of 35,000 members. CHADD is an active organization that is influencing the field in terms of consumer-based perspectives on the clinical practice and research agenda for ADHD. He will discuss the perspective and concerns of CHADD members.
· Discussant
Deborah Zarin, MD, Child Psychiatrist and AHRQ Office of Technology Assessment Dr. Zarin will summarize key issues as presented by the panelists as well as from her own research on ADHD. She will offer commentary on how to advance and encourage an ongoing dialogue/clinical research agenda to help resolve the controversy that continues to surround ADHD. She will then lead the discussion among the audience and panelists.
Learning Objectives:
Keywords: Child/Adolescent Mental Health,
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.